Invesco
ANGO icon

Invesco’s AngioDynamics ANGO Stock Holding History

Invesco’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25M Sell
109,807
-4,715
-4% -$51.1K ﹤0.01% 2763
2025
Q4 		$1.47M Sell
114,522
-12,884
-10% -$159K ﹤0.01% 2747
2025
Q3 		$1.42M Buy
127,406
+4,810
+4% +$46.4K ﹤0.01% 2765
2025
Q2 		$1.22M Buy
122,596
+2,667
+2% +$26.1K ﹤0.01% 2771
2025
Q1 		$1.13M Buy
119,929
+680
+0.6% +$7.15K ﹤0.01% 2783
2024
Q4 		$1.09M Buy
119,249
+1,451
+1% +$10.7K ﹤0.01% 2883
2024
Q3 		$916K Sell
117,798
-30,259
-20% -$219K ﹤0.01% 2943
2024
Q2 		$896K Sell
148,057
-4,237
-3% -$26.1K ﹤0.01% 2988
2024
Q1 		$894K Buy
152,294
+88,411
+138% +$525K ﹤0.01% 3046
2023
Q4 		$501K Buy
63,883
+3,244
+5% +$22.5K ﹤0.01% 3218
2023
Q3 		$443K Sell
60,639
-158,285
-72% -$1.32M ﹤0.01% 3257
2023
Q2 		$2.28M Sell
218,924
-60,377
-22% -$581K ﹤0.01% 2586
2023
Q1 		$2.89M Buy
279,301
+6,592
+2% +$84.4K ﹤0.01% 2487
2022
Q4 		$3.76M Buy
272,709
+7,621
+3% +$106K ﹤0.01% 2387
2022
Q3 		$5.42M Sell
265,088
-2,389
-0.9% -$52.4K ﹤0.01% 2181
2022
Q2 		$5.18M Sell
267,477
-833
-0.3% -$17.1K ﹤0.01% 2267
2022
Q1 		$5.78M Sell
268,310
-57,444
-18% -$1.3M ﹤0.01% 2301
2021
Q4 		$8.98M Sell
325,754
-50,817
-13% -$1.4M ﹤0.01% 2069
2021
Q3 		$9.77M Buy
376,571
+107,690
+40% +$2.88M ﹤0.01% 2015
2021
Q2 		$7.29M Sell
268,881
-6,508
-2% -$159K ﹤0.01% 2243
2021
Q1 		$6.44M Sell
275,389
-64,144
-19% -$1.3M ﹤0.01% 2239
2020
Q4 		$5.21M Buy
339,533
+61,757
+22% +$784K ﹤0.01% 2161
2020
Q3 		$3.35M Sell
277,776
-6,728
-2% -$63.9K ﹤0.01% 2221
2020
Q2 		$2.89M Buy
284,504
+2,625
+0.9% +$27.1K ﹤0.01% 2287
2020
Q1 		$2.94M Buy
281,879
+22,710
+9% +$285K ﹤0.01% 2182
2019
Q4 		$4.15M Sell
259,169
-69,359
-21% -$1.06M ﹤0.01% 2270
2019
Q3 		$6.05M Sell
328,528
-40,976
-11% -$801K ﹤0.01% 2023
2019
Q2 		$7.28M Sell
369,504
-106,832
-22% -$2.18M ﹤0.01% 1955
2019
Q1 		$10.9M Sell
476,336
-87,681
-16% -$1.9M ﹤0.01% 1523
2018
Q4 		$11.4M Sell
564,017
-41,375
-7% -$856K ﹤0.01% 1472
2018
Q3 		$13.2M Buy
605,392
+225,886
+60% +$5.02M ﹤0.01% 1549
2018
Q2 		$8.44M Buy
379,506
+148,990
+65% +$3.05M ﹤0.01% 1784
2018
Q1 		$3.98M Buy
230,516
+65,696
+40% +$1.1M ﹤0.01% 2104
2017
Q4 		$2.74M Buy
164,820
+13,967
+9% +$238K ﹤0.01% 2367
2017
Q3 		$2.58M Sell
150,853
-58,873
-28% -$989K ﹤0.01% 2384
2017
Q2 		$3.4M Buy
209,726
+11,416
+6% +$180K ﹤0.01% 2189
2017
Q1 		$3.44M Buy
198,310
+28,839
+17% +$482K ﹤0.01% 2247
2016
Q4 		$2.86M Buy
169,471
+36,376
+27% +$607K ﹤0.01% 2335
2016
Q3 		$2.33M Buy
133,095
+17,766
+15% +$288K ﹤0.01% 2439
2016
Q2 		$1.66M Buy
115,329
+4,448
+4% +$55.6K ﹤0.01% 2594
2016
Q1 		$1.36M Sell
110,881
-7,185
-6% -$79.4K ﹤0.01% 2719
2015
Q4 		$1.43M Buy
118,066
+7,639
+7% +$94.1K ﹤0.01% 2743
2015
Q3 		$1.46M Buy
110,427
+15,537
+16% +$235K ﹤0.01% 2701
2015
Q2 		$1.56M Buy
94,890
+9,780
+11% +$162K ﹤0.01% 2797
2015
Q1 		$1.51M Buy
85,110
+48
+0.1% +$892 ﹤0.01% 2794
2014
Q4 		$1.62M Buy
85,062
+53,253
+167% +$902K ﹤0.01% 2653
2014
Q3 		$436K Sell
31,809
-3,186
-9% -$45.5K ﹤0.01% 3377
2014
Q2 		$571K Buy
34,995
+200
+0.6% +$2.9K ﹤0.01% 3298
2014
Q1 		$548K Buy
34,795
+6,529
+23% +$106K ﹤0.01% 3352
2013
Q4 		$485K Sell
28,266
-8,413
-23% -$129K ﹤0.01% 3466
2013
Q3 		$484K Buy
36,679
+13,440
+58% +$158K ﹤0.01% 3417
2013
Q2 		$263K Buy
+23,239
New +$247K ﹤0.01% 3580

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Invesco's ANGO Position: Q1 2026 in Review

Invesco reduced its AngioDynamics (ANGO) stake by 4.1% in Q1 2026, selling an estimated $51.1K and leaving 109,807 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2763.

Invesco first reported a position in ANGO in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.2M in Q3 2018. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Invesco held 109,807 shares of AngioDynamics worth $1.25M as of Q1 2026.
  • Invesco sold 4,715 AngioDynamics shares in Q1 2026, an estimated $51.1K.
  • AngioDynamics made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #2763 holding.
  • Invesco first reported a position in AngioDynamics in Q2 2013 and has held it in 52 quarters since.
  • Invesco's AngioDynamics position peaked at $13.2M in Q3 2018.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.